Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q96BQ3
UPID:
TRI43_HUMAN
Alternative names:
-
Alternative UPACC:
Q96BQ3; Q53TJ7
Background:
Tripartite motif-containing protein 43 (TRIM43) plays a pivotal role in maintaining nuclear lamina integrity and facilitating the interaction between viral and host chromatin. Its unique function as an E3 ligase enables the targeted ubiquitination and subsequent proteasomal degradation of PCNT, a critical process in the cellular defense against herpesvirus infections.
Therapeutic significance:
Understanding the role of Tripartite motif-containing protein 43 could open doors to potential therapeutic strategies. Its specific antiviral mechanism against herpesvirus highlights its potential as a target for developing novel antiviral therapies.